Stepping on the scale

By giving other companies' short-read sequencers the ability to perform long reads, 10x Genomics Inc. expects researchers will be able to fully unlock the genome.

Co-founders CEO Serge Saxonov, COO and CTO Kevin Ness and President and CSO Ben Hindson previously worked together at genetic analysis company QuantaLife Inc., which was acquired by Bio-Rad Laboratories Inc. for $162 million plus milestones in 2011. ...